Indications |
Oral Benign prostatic hyperplasia Adult: 500 mcg daily (treatment for 6 mth may be required before benefit is obtained). |
Contraindications |
Severe liver impairment; pregnant women, children, adolescent. |
Warnings / Precautions |
Excreted in semen therefore use of condom is recommended. Women of childbearing potential should avoid handling dutasteride capsules. Advisable to exclude other causes of benign prostatic hypertrophy (e.g. prostate cancer, infection) before initiating therapy. |
Adverse Reactions |
Impotence; decreased libido; ejaculation disorders; breast tenderness and enlargement. |
Overdose Reactions |
Treatment is symptomatic and supportive. |
Drug Interactions |
Concurrent use with CYP3A4 inhibitors such as diltiazem and verapamil may increase serum levels of dutasteride. See Below for More dutasteride Drug Interactions |
Lab Interactions |
May interfere with interpretation of prostate-specific antigen test results. |
Mechanism of Actions |
Dutasteride has antiandrogenic properties. It inhibits 5α-reductase, thus preventing the conversion of testosterone to 5α-dihydrotestosterone which is the main androgen involved in causing prostate enlargement. Absorption: Absorbed from the GI tract, reaching peak serum concentration in 1-3 hr. Bioavailability: About 60%. Distribution: Highly bound to plasma proteins. Metabolism: Metabolised by CYP3A4 and CYP3A5. Excretion: Mainly excreted as metabolites in faeces. Elimination half-life: About 3-5 wk. |
Administration |
May be taken with or without food. |
Storage Conditions |
Oral: Store at 25°C. |
ATC Classification |
G04CB02 - dutasteride ; Belongs to the class of testosterone-5-alpha reductase inhibitors. Used in the treatment of benign prostatic hypertrophy. |
Storage |
Oral: Store at 25°C. |
Available As |
|
Dutasteride
Post Review about Dutasteride Click here to cancel reply.
Dutasteride Containing Brands
Dutasteride is used in following diseases
Drug - Drug Interactions of Dutasteride
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.